Correction: Jun 1, 2005

Jun 01, 2005

Premium

Greg Schiffman is the executive vice president and chief financial officer at Affymetrix, not the vice president of research.

Filed under

Microarrays & Multiplexing

microarrays

Breaking News

Oxford Nanopore Technologies to Raise £300M in IPO, Including £150M Investment by Oracle
Thermo Fisher Scientific Receives CE Mark for TaqPath COVID-19 RNase P 2.0 Testing Kit
Castle Biosciences Receives New York State Approval for DecisionDx DiffDx-Melanoma Test
FDA Approves Takeda's Exkivity With Thermo Fisher CDx for EGFR Exon20 Insertion-Positive NSCLC
Hong Kong-Based Prenetics to go Public via SPAC
NanoCellect Raises $35M to Support Commercial Push for Second-Generation Cell Sorter

The Scan

Removal Inquiry

The Wall Street Journal reports that US lawmakers are seeking additional information about the request to remove SARS-CoV-2 sequence data from a database run by the National Institutes of Health.

Likely to End in Spring

Free lateral flow testing for SARS-CoV-2 may end in the UK by next spring, the head of Innova Medical Group says, according to the Financial Times.

Searching for More Codes

NPR reports that the US Department of Justice has accused an insurance and a data mining company of fraud.

Genome Biology Papers on GWAS Fine-Mapping Method, COVID-19 Susceptibility, Rheumatoid Arthritis

In Genome Biology this week: integrative fine-mapping approach, analysis of locus linked to COVID-19 susceptibility and severity, and more.